Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05756257 · ClinicalTrials.gov registry record
Blood Pressure Variability and Ischemic Stroke Outcome
A clinical trial of Acute Ischemic Stroke and Blood Pressure Variability, sponsored by Yale University.
- Recruiting
- Registry status
- 150
- Enrollment target
- 3
- Study locations
NCT05756257: Recruiting study of Acute Ischemic Stroke and Blood Pressure Variability, sponsored by Yale University.
NCT05756257 is a study of Acute Ischemic Stroke and Blood Pressure Variability that is actively recruiting participants, run by Yale University. The registered enrollment target is 150 participants, below the 346-participant average among 25 other Acute Ischemic Stroke trials with a reported enrollment target (57% lower). The trial reports 3 study locations across 3 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05756257, a study of Acute Ischemic Stroke and Blood Pressure Variability, is actively recruiting participants, sponsored by Yale University.
- RECRUITING
- Registry status
- 150 participants
- Enrollment target
- 3
- Study locations
Study Summary
The goal of this observational study is to evaluate the role of blood pressure (BPV) variability in patients suffering from acute ischemic stroke. The main questions it aims to answer are: 1. To determine the association of BPV with functional/cognitive outcome after ischemic stroke. 2. To determine a pathophysiologic mechanism of BPV's deleterious effect on functional outcome. 3. To evaluate potential treatment targets to pharmacologically reduce BPV after ischemic stroke.
Primary Outcome
Modified Rankin Scale, the scale uses a range of 0-6 where higher scores indicate decreased function.
Conditions Studied
Study Locations (3)
Connecticut
- Yale-New Haven Hospital - New Haven
Illinois
- University of Chicago Medical Center - Chicago
Massachusetts
- Massachusetts General Hospital - Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 150 participants |
| Start Date | 2024-07-15 |
| Est. Completion | 2026-03-30 |
What NCT05756257 shows while recruiting
NCT05756257 is an observational study that tracks outcomes without assigning an intervention. The registered 150 participants enrollment target is mid-sized for trials with a published cap, below the 346-participant average among 25 other Acute Ischemic Stroke trials with a reported enrollment target (57% lower).
The record links to 2 conditions, with Acute Ischemic Stroke appearing as the primary indexed condition, and to 0 interventions.
NCT05756257 reports a single indexed study location in Connecticut, Illinois, Massachusetts.
Frequently Asked Questions
What is clinical trial NCT05756257 about?
NCT05756257 is a clinical study titled "Blood Pressure Variability and Ischemic Stroke Outcome". The goal of this observational study is to evaluate the role of blood pressure (BPV) variability in patients suffering from acute ischemic stroke. The main questions it aims to answer are: 1. To determine the association of BPV with functional/cognitive outcome after ischemic stroke. 2. To determin...
What is the current status of trial NCT05756257?
This trial is currently recruiting. The enrollment target is 150 participants. The study started on 2024-07-15. Estimated completion is 2026-03-30.
What conditions does trial NCT05756257 study?
This clinical trial studies the following conditions: Acute Ischemic Stroke, Blood Pressure Variability.
Who is sponsoring clinical trial NCT05756257?
This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05756257 being conducted?
This trial has 3 study locations across Connecticut, Illinois, Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Acute Ischemic Stroke
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05756257's enrollment target sits among peer trials
150 15th of 25 higher than 11 of 25 other Acute Ischemic Stroke trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Acute Ischemic Stroke trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Transcranial Direct Current Stimulation for Treatment of Acute Ischemic Stroke
RECRUITING · Phase 2
-
Non-invasive Vagus Nerve Stimulation to Reduce Inflammation and Brain Injury Blood Biomarkers Following an Acute Ischemic Stroke
RECRUITING · NA
-
Proximal Internal Carotid Artery Acute Stroke Secondary to Tandem or Local Occlusion Thrombectomy Trial
RECRUITING · Phase 3
-
Optimizing Reperfusion to Improve Outcomes and Neurologic Function
RECRUITING · Phase 2
-
SUMMIT RISE Study of Acute Ischemic Stroke Patients
RECRUITING · Phase 4
-
Hyperbaric Oxygen Therapy in Acute Ischemic Stroke Ischemic Stroke Recovery (Pro00061930)
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00412594 · 150 participants · Phase 2
Cladribine and Rituximab in Treating Patients With Hairy Cell Leukemia
- NCT01484730 · 150 participants
A Pilot Study to Evaluate Multi-Spectral and Laser Speckle Imaging and Multiphoton Microscopy During Vascular Occlusion
- NCT01985919 · 150 participants
Protocol for Facilitating the Acquisition of Research Bone Marrow and Blood Samples
- NCT02016248 · 150 participants · NA
SBRT Boost for Unfavorable Prostate Cancer'
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI